Your browser doesn't support javascript.
loading
Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants.
Wilkins, Deidre; Yuan, Yuan; Chang, Yue; Aksyuk, Anastasia A; Núñez, Beatriz Seoane; Wählby-Hamrén, Ulrika; Zhang, Tianhui; Abram, Michael E; Leach, Amanda; Villafana, Tonya; Esser, Mark T.
Afiliación
  • Wilkins D; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. deidre.wilkins@astrazeneca.com.
  • Yuan Y; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Chang Y; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Aksyuk AA; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Núñez BS; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Madrid, Spain.
  • Wählby-Hamrén U; Clinical Pharmacology & Quantitative Pharmacology, R&D, AstraZeneca, Gothenburg, Sweden.
  • Zhang T; Data Sciences and Quantitative Biology, R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Abram ME; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Leach A; Clinical Development, Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Villafana T; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
  • Esser MT; Vaccines & Immune Therapies, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.
Nat Med ; 29(5): 1172-1179, 2023 05.
Article en En | MEDLINE | ID: mdl-37095249

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Humans / Infant / Newborn Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Infecciones por Virus Sincitial Respiratorio Tipo de estudio: Clinical_trials Límite: Humans / Infant / Newborn Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos